StockWatch
·

Oxygenta Pharmaceutical Ltd Q3 FY25 Results

OXYGENTAPHQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue33.21137.1%
Total Income33.69128.4%
Expenditure38.66120.5%
PBT-4.9678.9%
Net Profit-3.9337.6%
OPM-19.71%15.08pp
NPM-11.66%7.68pp
EPS-1.0732.1%
View full financials

Informational and educational content only. Not investment advice.